查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1594889

全球狂犬病診斷市場

Rabies Diagnostics
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 89 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球狂犬病診斷市場預計將達到 28 億美元

狂犬病診斷的全球市場預計 2023 年為 19 億美元，預計到 2030 年將達到 28 億美元，在 2023-2030 年分析期間複合年成長率為 5.3%。螢光抗體檢測 (FAT) 是本報告分析的細分市場之一，預計複合年成長率為 5.1%，到分析期結束時將達到 9.101 億美元。分析期內，免疫組化檢測領域的複合年成長率預計為 5.3%。

美國市場預估為5.127億美元，中國預期複合年成長率為7.8%

預計 2023 年美國狂犬病診斷市場規模將達 5.127 億美元。中國作為全球第二大經濟體，預計2030年市場規模將達6.023億美元，2023年至2030年複合年成長率為7.8%。其他值得注意的區域市場包括日本和加拿大，在分析期間預計複合年成長率分別為 3.4% 和 4.3%。在歐洲，德國的複合年成長率預計為 3.9%。

狂犬病診斷：確保及時發現並預防這種致命疾病

什麼是狂犬病診斷？

狂犬病診斷是指用於檢測動物和人類狂犬病病毒的方法和工具。及時診斷至關重要，因為狂犬病在出現症狀時幾乎總是致命的，但早期發現可以透過及時有效的治療來預防。狂犬病診斷在公共衛生中發揮重要作用，包括預防疫情、確定治療策略以及為疫苗接種宣傳活動提供資訊。準確的診斷方法還可以幫助獸醫和野生動物專業人員識別受感染的動物，並允許採取管理措施來保護人類和動物族群。由於狂犬病會透過被感染動物咬傷的唾液傳播，影響中樞神經系統，並且可以傳播到幾乎所有溫血動物，因此有效的治療對於控制和預防狂犬病傳播至關重要。

早期、準確的狂犬病診斷對於評估咬傷受害者的潛在暴露至關重要。如果懷疑患有狂犬病，診斷結果可以幫助確定是否進行暴露後預防（PEP），這是一種在症狀出現之前進行的挽救生命的疫苗治療。狂犬病檢測對於清除野生動物和牲畜也至關重要，因為動物，尤其是蝙蝠、浣熊、狐狸和流浪狗等野生物種，是狂犬病的主要攜帶者。準確的診斷使衛生當局能夠開展監測計劃，識別有風險的地區，並將預防工作重點放在發病率高的地區。這些措施對於維護公眾健康和安全至關重要，特別是在狂犬病仍然流行的地區。

通常使用哪些診斷方法來檢測狂犬病？

狂犬病診斷的黃金標準是直接螢光抗體（DFA）測試，可分析動物死後的腦組織。此測試使用螢光標記的抗體，該抗體與狂犬病病毒抗原結合，並且可以直接在顯微鏡下觀察。 DFA 測試仍然是確認動物狂犬病的主要方法，因為它敏感、特異性且能快速提供結果。然而，它是侵入性的，因為它需要腦組織，並且只能在動物死亡後進行，限制其使用案例死亡或安樂死動物的疑似病例。

其他幾種診斷方法可用於人類或需要非侵入性測試時。逆轉錄聚合酵素鏈鎖反應(RT-PCR) 是一種分子技術，可檢測唾液、皮膚切片檢查和腦脊髓液等檢體中是否存在狂犬病病毒 RNA。 RT-PCR 可以對活體患者進行，因此可以提供一種在死亡前檢測狂犬病的方法，但它的敏感性不如 DFA，並且可能容易出現假陰性，尤其是在感染的早期階段。酵素結合免疫吸附檢測法(ELISA) 和血清學測試也可用於檢測血液中的狂犬病抗體，但這些通常表明過去的暴露情況，而不是診斷活動性性行為感染。結合這些方法將實現更全面的診斷方法，並提高檢測和應對動物和人類狂犬病的能力。

狂犬病診斷如何隨著新技術的發展而發展？

狂犬病診斷的最新進展集中在提高早期檢測的速度、可及性和非侵入性選擇。狂犬病快速診斷測試通常基於橫向流動化驗技術，旨在提供現場快速測試結果，而不需要專門的測試設備。這些快速檢測在現場環境中特別有用，因為它們允許獸醫和醫療專業人員快速評估疑似病例，並在必要時實施隔離和疫苗接種。儘管不如 DFA 測試準確，但這些攜帶式診斷儀是初步篩檢的寶貴工具，特別是在檢測設施有限的農村和資源有限地區。

分子診斷的創新，包括即時PCR和次世代定序，也正在提高檢測狂犬病的能力。即時PCR技術可以定量檢體中的病毒量，因此即使在病毒量較低的情況下也能進行高靈敏度檢測，有助於人類和動物的早期診斷。此外，正在研究開發一種非侵入性診斷方法，利用唾液或眼淚來檢測活體動物的狂犬病，從而可以對家養寵物進行早期檢測，並預防狂犬病疑似病例，從而可能減少安樂死的需要。隨著診斷技術的進步，我們的目標是開發更容易取得、更可靠、更人性化的狂犬病檢測方法，以改善不同環境下的疾病控制和預防。

推動狂犬病診斷市場成長的因素有哪些？

狂犬病診斷市場的成長是由狂犬病預防意識的提高、診斷技術的進步以及高風險地區對可用診斷方法的需求不斷增加等因素所推動的。隨著人們對狂犬病危險和早期診斷重要性的認知不斷提高，醫療機構和獸醫組織正在優先考慮狂犬病診斷檢測，以控制和預防狂犬病的爆發。此外，世界許多地區的快速都市化和人類與野生動物互動的增加增加了狂犬病感染的可能性，並增加了對廣泛診斷能力的需求。

此外，技術的進步使得攜帶式快速檢測和分子檢測技術可以在現場和臨床環境中使用，使狂犬病診斷變得更加容易。這些創新解決了遠端檢測的挑戰，特別是在狂犬病仍然流行的地區，如非洲、亞洲和拉丁美洲。此外，政府和非營利組織正在共同努力減少全球狂犬病，例如世界衛生組織的「零除 30」目標，即到 2030 年消除因狗傳播狂犬病造成的人類死亡。狂犬病診斷。這些綜合因素正在推動狂犬病診斷市場的成長，並支持全球減少狂犬病感染和改善公共衛生結果的努力。

部分

方法學（螢光抗體檢測（FAT）、免疫組織化學、擴增、組織學、血清學）技術（ELISA/免疫組織化學、層析法、PCR、其他技術）；

受訪企業舉例（共34家）

  • Abbexa Ltd.
  • Aviva Systems Biology Corporation
  • BioNote, Inc.
  • Bio-Rad Laboratories, Inc.
  • Creative Diagnostics
  • Demeditec Diagnostics GmbH
  • Express Biotech International Inc.
  • Merck KGaA
  • MyBioSource.com
  • Norgen Biotek Corp.

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 比賽

簡介目錄
Product Code: MCP22670

Global Rabies Diagnostics Market to Reach US$2.8 Billion by 2030

The global market for Rabies Diagnostics estimated at US$1.9 Billion in the year 2023, is expected to reach US$2.8 Billion by 2030, growing at a CAGR of 5.3% over the analysis period 2023-2030. Fluorescent Antibody Tests (FAT), one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$910.1 Million by the end of the analysis period. Growth in the Immunohistochemical Tests segment is estimated at 5.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$512.7 Million While China is Forecast to Grow at 7.8% CAGR

The Rabies Diagnostics market in the U.S. is estimated at US$512.7 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$602.3 Million by the year 2030 trailing a CAGR of 7.8% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.4% and 4.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.

Rabies Diagnostics: Ensuring Timely Detection and Prevention of a Deadly Disease

What Are Rabies Diagnostics and Why Are They Critical in Public Health?

Rabies diagnostics refer to the methods and tools used to detect the rabies virus in animals and humans. Timely diagnosis is essential because rabies is nearly always fatal once symptoms appear, but it is preventable with prompt and effective treatment if identified early. Rabies diagnostics play a crucial role in public health by helping prevent outbreaks, guiding treatment decisions, and informing vaccination campaigns. Accurate diagnostic methods also aid veterinarians and wildlife professionals in identifying infected animals, allowing them to implement control measures to protect both human and animal populations. The disease, which is transmitted through saliva from an infected animal bite, affects the central nervous system and can spread to nearly any warm-blooded species, making effective diagnostics vital for controlling and preventing rabies transmission.

Early and precise rabies diagnostics are essential for assessing possible exposure in bite victims. If rabies is suspected, diagnostics help guide the decision to administer post-exposure prophylaxis (PEP), a life-saving vaccine treatment given before symptoms develop. Rabies testing is also crucial in wildlife and domestic animal control, as animals, particularly wild species like bats, raccoons, foxes, and stray dogs, are primary rabies carriers. Through accurate diagnostics, health authorities can implement surveillance programs, identify at-risk areas, and focus preventive efforts on regions with high incidence rates. These actions are critical in maintaining public health and safety, especially in areas where rabies remains endemic.

What Diagnostic Methods Are Commonly Used to Detect Rabies?

The gold standard for rabies diagnosis is the Direct Fluorescent Antibody (DFA) Test, which involves analyzing brain tissue from an animal postmortem. This test uses fluorescently labeled antibodies that bind to rabies virus antigens, allowing for direct visualization under a microscope. The DFA test is highly sensitive and specific, providing results in a short time frame, and remains the primary method for confirming rabies in animals. However, because it requires brain tissue, it is invasive and can only be performed after the animal's death, limiting its use to suspected cases in animals that have died or been euthanized.

For humans and in situations where non-invasive testing is preferred, several other diagnostic methods are used. Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) is a molecular technique that detects the presence of rabies virus RNA in samples like saliva, skin biopsies, and cerebrospinal fluid. RT-PCR can be performed on living patients, providing a way to detect rabies before death, though it is less sensitive than DFA and can yield false negatives, especially in early stages of infection. Enzyme-Linked Immunosorbent Assay (ELISA) and serological tests are also used to detect rabies antibodies in blood, though they are typically more useful for confirming previous exposure rather than diagnosing active infection. Combined, these methods enable a more comprehensive diagnostic approach, enhancing the ability to detect and respond to rabies in both animals and humans.

How Are Rabies Diagnostics Evolving with New Technology?

Recent advancements in rabies diagnostics focus on improving speed, accessibility, and non-invasive options for early detection. Rapid rabies diagnostic tests, often based on lateral flow assay technology, have been developed to provide quick, on-site testing results without the need for specialized laboratory equipment. These rapid tests are particularly useful in field settings, allowing veterinarians and health professionals to assess suspected cases quickly and implement quarantine or vaccination measures as needed. Although not as precise as the DFA test, these portable diagnostics offer a valuable tool for preliminary screening, especially in rural or resource-limited areas where access to laboratory facilities may be limited.

Innovations in molecular diagnostics, including real-time PCR and next-generation sequencing, are also enhancing rabies detection capabilities. Real-time PCR techniques can quantify viral load in samples, providing more sensitive detection even at lower viral levels, which is beneficial for early diagnosis in humans and animals. Additionally, research is ongoing into developing non-invasive diagnostic methods that use saliva or tears to detect rabies in living animals, which could potentially enable early detection in domestic pets and reduce the need for euthanasia in suspect cases. As diagnostic technology advances, the goal is to create more accessible, reliable, and humane rabies testing methods that improve disease management and prevention across diverse settings.

What Factors Are Driving the Growth in the Rabies Diagnostics Market?

The growth in the rabies diagnostics market is driven by factors such as increasing awareness of rabies prevention, advancements in diagnostic technologies, and the rising demand for accessible diagnostics in high-risk regions. As awareness grows around the dangers of rabies and the importance of early diagnosis, healthcare authorities and veterinary organizations are prioritizing rabies diagnostic testing to control and prevent outbreaks. Furthermore, rapid urbanization in many parts of the world has increased human-wildlife interactions, raising the potential for rabies exposure and the need for widespread diagnostic capabilities.

Technological advancements have also made rabies diagnostics more accessible, with portable rapid tests and molecular testing techniques now available for field and clinical use. These innovations address the challenges of testing in remote areas, particularly in regions of Africa, Asia, and Latin America, where rabies remains endemic. Additionally, government initiatives and collaborations with non-profit organizations to reduce rabies cases globally, such as the World Health Organization’s “Zero by 30” goal to eliminate human deaths from dog-mediated rabies by 2030, have created a supportive environment for rabies diagnostics development and deployment. These combined factors are driving growth in the rabies diagnostics market, supporting efforts to reduce rabies transmission and improve public health outcomes worldwide.

SCOPE OF STUDY:

The report analyzes the Rabies Diagnostics market in terms of US$ Thousand by the following Method; Technology, and Geographic Regions/Countries:

Segments:

Method (Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations, Serology Tests); Technology (ELISA / Immunohistochemistry, Chromatography, PCR, Other Technologies)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

  • Abbexa Ltd.
  • Aviva Systems Biology Corporation
  • BioNote, Inc.
  • Bio-Rad Laboratories, Inc.
  • Creative Diagnostics
  • Demeditec Diagnostics GmbH
  • Express Biotech International Inc.
  • Merck KGaA
  • MyBioSource.com
  • Norgen Biotek Corp.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Rabies Diagnostics - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Rabies in Developing Regions Drives Demand for Advanced Rabies Diagnostic Solutions
    • Increased Focus on Zoonotic Disease Control and Prevention Spurs Growth in Rabies Diagnostics
    • Advancements in Rapid Diagnostic Techniques Enhance Accessibility and Accuracy of Rabies Testing
    • Growing Awareness Programs for Rabies Prevention and Early Detection Expand Market for Diagnostic Tools
    • Expansion of Veterinary Diagnostics for Rabies Testing in Domestic and Wild Animals Supports Market Growth
    • Technological Innovations in Point-of-Care (POC) Rabies Testing Boost Adoption in Remote and Low-Infrastructure Regions
    • Rising Adoption of Molecular Diagnostic Techniques Strengthens Accuracy and Sensitivity of Rabies Diagnostics
    • Growing Use of Immunohistochemistry (IHC) and ELISA Techniques in Rabies Diagnostics Expands Laboratory Testing Market
    • Increasing Prevalence of Rabies in Asia and Africa Spurs Demand for Field-Ready Diagnostic Tools
    • Rising Demand for Cost-Effective and User-Friendly Diagnostic Kits Expands Accessibility in Low-Resource Settings
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Rabies Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Rabies Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Rabies Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Fluorescent Antibody Tests (FAT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Fluorescent Antibody Tests (FAT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Fluorescent Antibody Tests (FAT) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Immunohistochemical Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Immunohistochemical Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Immunohistochemical Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Amplification Methods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Amplification Methods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Amplification Methods by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Histologic Examinations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Histologic Examinations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Histologic Examinations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Serology Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Serology Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Serology Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for ELISA / Immunohistochemistry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for ELISA / Immunohistochemistry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for ELISA / Immunohistochemistry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Chromatography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Chromatography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 24: World 16-Year Perspective for Chromatography by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for PCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 26: World Historic Review for PCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 27: World 16-Year Perspective for PCR by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 29: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 30: World 16-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 31: World Rabies Diagnostics Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Rabies Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2014, 2024 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2014, 2024 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2014, 2024 & 2030
  • JAPAN
    • Rabies Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: Japan 16-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2014, 2024 & 2030
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2014, 2024 & 2030
  • CHINA
    • Rabies Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 50: China Recent Past, Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: China 16-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2014, 2024 & 2030
    • TABLE 53: China Recent Past, Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: China 16-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2014, 2024 & 2030
  • EUROPE
    • Rabies Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Rabies Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Rabies Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Rabies Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2014, 2024 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: Europe 16-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2014, 2024 & 2030
  • FRANCE
    • Rabies Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 65: France Recent Past, Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: France 16-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2014, 2024 & 2030
    • TABLE 68: France Recent Past, Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: France Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: France 16-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2014, 2024 & 2030
  • GERMANY
    • Rabies Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Germany 16-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2014, 2024 & 2030
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: Germany 16-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Italy 16-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2014, 2024 & 2030
    • TABLE 80: Italy Recent Past, Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Italy 16-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Rabies Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 83: UK Recent Past, Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: UK 16-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2014, 2024 & 2030
    • TABLE 86: UK Recent Past, Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: UK 16-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 89: Spain Recent Past, Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Spain 16-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2014, 2024 & 2030
    • TABLE 92: Spain Recent Past, Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Spain Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Spain 16-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 95: Russia Recent Past, Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Russia 16-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2014, 2024 & 2030
    • TABLE 98: Russia Recent Past, Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Russia Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Russia 16-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Rest of Europe 16-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2014, 2024 & 2030
    • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Rest of Europe Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Rest of Europe 16-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Rabies Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Rabies Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Rabies Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Asia-Pacific 16-Year Perspective for Rabies Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: Asia-Pacific 16-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2014, 2024 & 2030
    • TABLE 113: Asia-Pacific Recent Past, Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Asia-Pacific Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: Asia-Pacific 16-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Rabies Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 116: Australia Recent Past, Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: Australia 16-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2014, 2024 & 2030
    • TABLE 119: Australia Recent Past, Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Australia Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: Australia 16-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2014, 2024 & 2030
  • INDIA
    • Rabies Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 122: India Recent Past, Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: India Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: India 16-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2014, 2024 & 2030
    • TABLE 125: India Recent Past, Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: India Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: India 16-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: South Korea 16-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2014, 2024 & 2030
    • TABLE 131: South Korea Recent Past, Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 132: South Korea Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: South Korea 16-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 16-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2014, 2024 & 2030
    • TABLE 137: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Rest of Asia-Pacific Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Rest of Asia-Pacific 16-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Rabies Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Rabies Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Rabies Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Latin America 16-Year Perspective for Rabies Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: Latin America 16-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2014, 2024 & 2030
    • TABLE 146: Latin America Recent Past, Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Latin America Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 148: Latin America 16-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 151: Argentina 16-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2014, 2024 & 2030
    • TABLE 152: Argentina Recent Past, Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Argentina Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 154: Argentina 16-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 157: Brazil 16-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2014, 2024 & 2030
    • TABLE 158: Brazil Recent Past, Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Brazil Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 160: Brazil 16-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 163: Mexico 16-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2014, 2024 & 2030
    • TABLE 164: Mexico Recent Past, Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Mexico Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 166: Mexico 16-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 169: Rest of Latin America 16-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2014, 2024 & 2030
    • TABLE 170: Rest of Latin America Recent Past, Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Rest of Latin America Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 172: Rest of Latin America 16-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Rabies Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Rabies Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Rabies Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 175: Middle East 16-Year Perspective for Rabies Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 178: Middle East 16-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2014, 2024 & 2030
    • TABLE 179: Middle East Recent Past, Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Middle East Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 181: Middle East 16-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 182: Iran Recent Past, Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 184: Iran 16-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2014, 2024 & 2030
    • TABLE 185: Iran Recent Past, Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Iran Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 187: Iran 16-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 188: Israel Recent Past, Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 190: Israel 16-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2014, 2024 & 2030
    • TABLE 191: Israel Recent Past, Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Israel Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 193: Israel 16-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 196: Saudi Arabia 16-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2014, 2024 & 2030
    • TABLE 197: Saudi Arabia Recent Past, Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Saudi Arabia Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 199: Saudi Arabia 16-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 200: UAE Recent Past, Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 202: UAE 16-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2014, 2024 & 2030
    • TABLE 203: UAE Recent Past, Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 204: UAE Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 205: UAE 16-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 208: Rest of Middle East 16-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2014, 2024 & 2030
    • TABLE 209: Rest of Middle East Recent Past, Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Rest of Middle East Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 211: Rest of Middle East 16-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2014, 2024 & 2030
  • AFRICA
    • Rabies Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 212: Africa Recent Past, Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 214: Africa 16-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2014, 2024 & 2030
    • TABLE 215: Africa Recent Past, Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 216: Africa Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 217: Africa 16-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2014, 2024 & 2030

IV. COMPETITION